MEMP1972A, an anti-M1 prime monoclonal antibody, reduces serum IgE in healthy and allergic rhinitis subjects

H. Scheerens, W. Putnam, Y. Zheng, Y. Wang, S. Mosesova, R. Maciuca, C. Liao, L. Wu, J. Matthews, J. Harris (San Francisco, United States Of America)

Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Session: The best of pharmacology treatment for asthma and COPD
Session type: Poster Discussion
Number: 4831
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Scheerens, W. Putnam, Y. Zheng, Y. Wang, S. Mosesova, R. Maciuca, C. Liao, L. Wu, J. Matthews, J. Harris (San Francisco, United States Of America). MEMP1972A, an anti-M1 prime monoclonal antibody, reduces serum IgE in healthy and allergic rhinitis subjects. Eur Respir J 2012; 40: Suppl. 56, 4831

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment with omalizumab (rhuMAb-E25), a monoclonal anti-IgE antibody induces effective changes in subjects with allergic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 37s
Year: 2001

Effects of anti-M1 prime monoclonal antibody, MEMP1972A following allergen challenge in patients with mild asthma
Source: Annual Congress 2012 - New bronchodilators and other novel drugs for asthma and COPD
Year: 2012

Effect of humanized monoclonal anti-IgE antibody, omalizumab, on allergen challenge-induced nasal response in subjects with allergic rhinitis and allergic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 36s
Year: 2001

The effects of efalizumab, an anti-CD11a monoclonal antibody (hu1124), on allergen-induced airway inflammation in atopic asthmatic subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 350s
Year: 2001

The rationale for treating allergic asthma with anti-IgE
Source: Eur Respir Rev 2007; 16: 61-66
Year: 2007



Long-term asthma control with omalizumab, an anti-IgE monoclonal antibody, in patients with severe allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 47s
Year: 2005

Serum level of specific IgG antibody for aspergillus and its association with severity of asthma in asthmatic children
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012

Tolerability assessment of a recombinant humanized monoclonal anti-IgE antibody (omalizumab) as a treatment for seasonal allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 116s
Year: 2002

The relationship between total IgE and specific antibody testing by Immunocap in screening allergic asthma
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020

A monoclonal antibody to IL-1B attenuates the late asthmatic response to antigen challenge in patients with mild asthma
Source: Annual Congress 2006 - Novel treatments for asthma
Year: 2006


Omalizumab: an anti-immunoglobulin E antibody for the treatment of allergic respiratory diseases
Source: Eur Respir Rev 2008; 17: 1-9
Year: 2008



Omalizumab, a recombinant humanized monoclonal anti-IgE antibody, decreases the risk of serious asthma exacerbations requiring hospitalization in patients with moderate-to-severe allergic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 37s
Year: 2001

Correlation between grass pollen specific IgG,IgG4 and IgE in patients treated with SIT
Source: Eur Respir J 2002; 20: Suppl. 38, 507s
Year: 2002

IgE antibodies in children with different types of allergy
Source: Eur Respir J 2001; 18: Suppl. 33, 435s
Year: 2001

Subcutaneuous injection of monoclonal antibody anti-DEC205 conjugated with ovalbumin atenuates allergic lung inflammation of animals previously sensitized to allergen
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012

The influence of the allergen-specific immunotherapy (ASIT) against the backdrop of an immunomodulator in patients suffering from seasonal allergic rhinitis (SAR) on the level of cytokines, IgE and IgG.
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020


Evaluation of bronchial hyperreactivity and other functional parameters in severe asthma patients treated with anti-interleukin-5 monoclonal antibody (IL5)
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
Source: Eur Respir J 2001; 18: 254-261
Year: 2001



Detection of IgG and IgE-abs to herpesviruses in asthmatic patients
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009

The association of serum IgG antibody with symptoms of hypersensitivity pneumonitis
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006